Infectious Diseases Stocks
Biopharmaceutical firms in this sector focus on the research, development, and commercialization of therapeutics, vaccines, and diagnostic tools designed to combat viral, bacterial, and fungal pathogens.
As of Oct 23, 2026, Infectious Diseases has 66 US-listed companies worth $938B combined. The median member moved -2.1% over the past week; INDP led among the 25 largest at +20.2% and NVAX trailed at -13.9%.
Companies in Infectious Diseases
- MRK – Merck & Company Inc, $363B
- GILD – Gilead Sciences Inc, $193B
- GSK – GlaxoSmithKline PLC ADR, $103B
- SNY – Sanofi ADR, $99.7B
- MRNA – Moderna Inc, $79.9B
- BNTX – BioNTech SE, $22.9B
- STE – STERIS plc, $22.6B
- INSM – Insmed Inc, $20.4B
- PCVX – Vaxcyte Inc, $9.9B
- IBRX – Immunitybio Inc, $8.8B
- ADMA – ADMA Biologics Inc, $2.4B
- NVAX – Novavax Inc, $1.9B
- VIR – Vir Biotechnology Inc, $1.8B
- AMPH – Amphastar P, $1.1B
- QDEL – Quidel Corporation, $885M
- ABUS – Arbutus Biopharma Corp, $648M
- CRMD – CorMedix Inc, $576M
- VALN – Valneva SE ADR, $527M
- CERS – Cerus Corporation, $459M
- AVIR – Atea Pharmaceuticals Inc, $413M
- ASMB – Assembly Biosciences Inc, $409M
- INDP – Indaptus Therapeutics Inc, $380M
- EBS – Emergent Biosolutions Inc, $354M
- ENTA – Enanta Pharmaceuticals Inc, $352M
- TTRX – Turn Therapeutics Inc. Common Stock, $337M
- ARCT – Arcturus Therapeutics Holdings Inc, $308M
- OSUR – OraSure Technologies Inc, $260M
- NNNN – Anbio Biotechnology Class A Ordinary Shares, $205M
- IVVD – Invivyd Inc., $182M
- ANTX – AN2 Therapeutics Inc, $166M
- UPB – Upstream Bio, Inc., $151M
- VXRT – Vaxart Inc, $105M
- ARMP – Armata Pharmaceuticals Inc, $103M
- ANIX – Anixa Biosciences Inc, $101M
- TNXP – Tonix Pharmaceuticals Holding Corp, $93.1M
- PTHS – Pelthos Therapeutics Inc., $85M
- SPRO – Spero Therapeutics Inc, $71.6M
- TVGN – Tevogen Bio Holdings Inc., $46M
- SCYX – Scynexis Inc, $37.7M
- EVAX – Evaxion Biotech AS, $36.5M
- ALGS – Aligos Therapeutics Inc, $33.3M
- NNVC – NanoViricides Inc, $33.2M
- MCRB – Seres Therapeutics Inc, $29.5M
- PLRZ – Polyrizon Ltd. Ordinary Shares, $24.9M
- COCP – Cocrystal Pharma Inc, $20.8M
- IMRN – Immuron Ltd ADR, $9.4M
- BMRA – Biomerica Inc, $8.6M
- AEMD – Aethlon Medical Inc, $8.5M
- CUBT – Curative Biotechnology Inc, $8.4M
- ACXP – Acurx Pharmaceuticals LLC, $7.2M
- AIM – AIM ImmunoTech Inc, $6.7M
- IMNN – Imunon Inc, $6.1M
- TRIB – Trinity Biotech plc, $5.5M
- CODX – Co-Diagnostics, Inc. Common Stock, $4.6M
- RDHL – Redhill Biopharma Ltd, $3M
- SXTP – 60 Degrees Pharmaceuticals, Inc. Common Stock, $3M
- GOVX – GeoVax Labs Inc, $2.9M
- DCOY – Decoy Therapeutics Inc., $2.8M
- VRAX – Virax Biolabs Group Limited Ordinary Shares, $1.8M
- MTNB – Matinas BioPharma Holdings Inc, $1.7M
- LABT – Lakewood-Amedex Biotherapeutics Inc. Common Stock, $1.4M
- SRNE – Sorrento Therape, $441,024
- OCEA – Ocean Biomedical Inc., $185,892
- TTOO – T2 Biosystms Inc, $19,631
- ARDS – Aridis Pharmaceuticals Inc, $4,457
- ONTX – Onconova Therapeutics Inc